Quantitative prediction of bone mineral density by using bone turnover markers in response to antiresorptive agents in postmenopausal osteoporosis: A model-based meta-analysis.

British Journal of Clinical Pharmacology
Junyi WuQingshan Zheng

Abstract

This study aimed to predict time course of bone mineral density (BMD) by using corresponding response of bone turnover markers (BTMs) in women with postmenopausal osteoporosis under antiresorptive treatments. Data were extracted from literature searches in accessible public database. Time courses of percent change from baseline in serum C-telopeptide of type 1 collagen (sCTX) and N-telopeptide of type 1 collagen were described by complex exponential onset models. The relationship between BTM changes and BMD changes at lumbar spine and total hip was described using a multiscale indirect response model. The dataset included 41 eligible published trials of 5 US-approved antiresorptive agents (alendronate, ibandronate, risedronate, zoledronic acid and denosumab), containing over 28 800 women with postmenopausal osteoporosis. The time courses of BTM changes for different drugs were differentiated by maximal effect and onset rate in developed model, while sCTX responses to zoledronic acid and denosumab were captured by another model formation. Furthermore, asynchronous relationship between BTMs and BMD was described by a bone remodelling-based semimechanistic model, including zero-order production and first-order elimination induced ...Continue Reading

References

Sep 1, 1992·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L J MeltonB L Riggs
Aug 18, 1997·The American Journal of Medicine·O Johnell
Sep 1, 1999·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R MarcusJ Kelaghan
Feb 15, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy
Jun 7, 2002·Lancet·Steven R Cummings, L Joseph Melton
Oct 17, 2002·JAMA : the Journal of the American Medical Association·Steven R CummingsDennis M Black
Sep 3, 2004·Journal of the American Geriatrics Society·Brent C TaylorKristine E Ensrud
Nov 17, 2005·Archives of Internal Medicine·Daniel H SolomonM Alan Brookhart
Dec 3, 2005·The Journal of Clinical Investigation·Lawrence G Raisz
Feb 24, 2006·The New England Journal of Medicine·Michael R McClungUNKNOWN AMG 162 Bone Loss Study Group
Jun 7, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Susan K BrennemanEthel S Siris
Jun 20, 2006·Lancet·Philip Sambrook, Cyrus Cooper
Dec 6, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Russel BurgeAnna Tosteson
Mar 14, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Nguyen D NguyenTuan V Nguyen
Feb 7, 2009·Bone·John A KanisEugene McCloskey
Apr 3, 2009·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Pierre D DelmasUNKNOWN HORIZON-PFT Research Group
Oct 31, 2009·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Henry G BoneB Avery Ince
Nov 11, 2009·PLoS Medicine·Emily BanksUNKNOWN Million Women Study Collaborators
Jan 14, 2010·Clinical Pharmacokinetics·Teun M PostMeindert Danhof
Apr 1, 2011·Lancet·Tilman D RachnerLorenz C Hofbauer
Jun 10, 2011·Clinical Pharmacokinetics·Venkatesh Pilla ReddyJohannes H Proost
Sep 7, 2011·Nature Reviews. Endocrinology·Jian Sheng Chen, Philip N Sambrook
Jun 6, 2012·Nature Reviews. Rheumatology·Kim Naylor, Richard Eastell
Aug 8, 2012·Therapeutic Advances in Musculoskeletal Disease·Paul D Miller
Jan 1, 2012·CPT: Pharmacometrics & Systems Pharmacology·M C Peterson, M M Riggs
Jul 23, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Richard EastellSteve Deacon
Aug 21, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Shreyasee AminL Joseph Melton
Jun 11, 2014·The Journal of Clinical Endocrinology and Metabolism·Jaap W MandemaJuan Jose Perez Ruixo
Jan 21, 2016·The New England Journal of Medicine·Dennis M Black, Clifford J Rosen
Jul 12, 2017·The Lancet. Diabetes & Endocrinology·Richard Eastell, Pawel Szulc
Jul 19, 2017·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Dennis M BlackNicola Napoli
Jul 26, 2018·CPT: Pharmacometrics & Systems Pharmacology·Chihiro Hasegawa, Stephen B Duffull
Apr 18, 2019·Clinical Pharmacology and Therapeutics·Vijay V Upreti, Karthik Venkatakrishnan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
R CivitelliN Napoli
Climacteric : the Journal of the International Menopause Society
K HenriksenM A Karsdal
© 2021 Meta ULC. All rights reserved